Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children

Table 2 Basal characteristics of groups and secondary outcomes

	GC Group n= 20	GARLB Group n = 23	GB Group n = 21	P value
Boys (%)	9 (45)	15 (65)	12 (57)	0.40*
Age, months (IQR)	11 (8.5)	6 (5)	8 (7)	0.08^†
Weight, gr. (IQR)	7775 (1769.5)	7652.5 (2765)	7800 (2115)	0.92^†
Duration(IQR) of diarrhoea before treatment (hours)	48 (24)	72 (36)	48 (48)	0.17^†
Median hours of hospitalization (IQR)	89.5 (117)	72 (36)	60 (41)	0.31^₤
N° (%) of children with fever	19 (95)	21 (91)	18 (86)	0.59*
Median (IQR) duration of fever (hours)	67 (60)	48 (36)	18 (53)	0.0042^†
N° (%) of children vomiting	13 (65)	10 (43.5)	11 (52.4)	0.37*
Median (IQR) duration of vomiting (hours)	42.5 (69.5)	0 (25)	4 (44)	0.041^‡

Patients' characteristics on admission. Duration of hospitalization, of fever and of vomiting after treatment.
IQR= Intercuartile Range
* Chi square test
† Kruskall - Wallis test
₤ Kruskall - Wallis test, adjusted p value, median comparison between GC and GB groups.
‡ Kruskall - Wallis test, adjusted p value, median comparison between GC and GARLB groups.

ISSN: 1471-2334